A New Place in Human Immunology

Four class 1 molecules are constructed around a fragment of protein from a virus to make a tetramer Which of the following comments are immunologists making about the tetramer assay these days? A) "It's changed our life." B) "It's just an assay." If you answered "both," you're up on your immunology. The tetramer is just an assay, but it's been making immunologists giddy in the last few years. Peter Doherty of St. Jude Children's Research Hospital made the first statement (wh

Written byCynthia Fox
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


Four class 1 molecules are constructed around a fragment of protein from a virus to make a tetramer
Which of the following comments are immunologists making about the tetramer assay these days?

A) "It's changed our life."

B) "It's just an assay."

If you answered "both," you're up on your immunology. The tetramer is just an assay, but it's been making immunologists giddy in the last few years. Peter Doherty of St. Jude Children's Research Hospital made the first statement (while acknowledging the second) most recently. He shared the 1996 Nobel Prize for physiology or medicine for his 1970s discovery that T cells must recognize two targets on the surface of a tumor, viral, or graft cell before killing it: the major histocompatibility complex (MHC) molecule and the antigen it cradles. But like all other immunologists, he didn't know his own antigen-specific CD8 "killer" T cells until the tetramer showed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies